Literature DB >> 25673207

Time-dependent expression of PEDF and VEGF in blood serum and retina of rats with oxygen-induced retinopathy.

Chun-Tao Lei1, Xiao-Ling Wu2, Jie Peng3, Xiao-Feng Chen4, Li-Feng Qiao1, Ying-Chuan Fan1, Jian-Bin Hu1.   

Abstract

The effects of the balance changes of pigment epithelium growth factor (PEDF) and vascular endothelial growth factor (VEGF) in whole-body and retinal tissue on rats with oxygen-induced retinopathy were investigated. Forty-eight neonatal SD rats at the age of 7 days were randomly divided into 4 groups. The neonatal rats in experimental groups were exposed to 75% to 80% oxygen for 5 days and then to normal air, and those in control groups were kept feeding in normal air. At the age of 17 and 22 days, all the neonatal rats received retina angiography with FITC-dextran and the pathological changes of retinal vessels and perfusion were observed. HE staining of the tissue section and the number counting of endothelial cells extending beyond the inner limiting membrane were performed to evaluate the endothelial proliferation. Immunohistochemistry was applied to detect the expression of PEDF and VEGF in retinal tissue, and ELISA to detect their expression in serum. A hypoxic-ischemic proliferation of retina and more endothelial cells extending beyond the inner limiting membrane were found in the neonatal rats in both experimental groups of 17-day old and 22-day old as compared with those in control group with the difference being statistically significant (P<0.01). VEGF staining of the rats in the 17-day old experimental group was significantly stronger, with an increasing positive rate, than that of the rats in the 17-day old control group (P<0.01). PEDF staining of the rats of 22 days old was weaker than that of the rats of 17 days old in the experimental groups (P<0.01). There was no significant difference in serum VEGF concentration among all groups (P>0.05). The serum PEDF concentration in the rats of 17 days old in experimental group was decreased significantly as compared with that in the rats of 17 days old in control group (P<0.01), and in experimental groups, the serum PEDF concentration of the rats of 22 days old was increased as compared with that of the rats of 17 days old (P<0.01). In conclusion, the obviously decreased serum PEDF concentration and the abnormal enhanced expression of VEGF density in local retinal tissue broke down the balance of PEDF/VEGF in whole-body or local tissues, which might play an important role in retinal vascular proliferation.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25673207     DOI: 10.1007/s11596-015-1402-9

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  21 in total

Review 1.  PEDF in angiogenic eye diseases.

Authors:  J Tombran-Tink
Journal:  Curr Mol Med       Date:  2010-04       Impact factor: 2.222

2.  Comparison of the levels of hepatocyte growth factor and vascular endothelial growth factor in aqueous fluid and serum with grades of retinopathy in patients with diabetes mellitus.

Authors:  K Shinoda; S Ishida; S Kawashima; T Wakabayashi; T Matsuzaki; M Takayama; K Shinmura; M Yamada
Journal:  Br J Ophthalmol       Date:  1999-07       Impact factor: 4.638

3.  Antiangiogenesis effects of endostatin in retinal neovascularization.

Authors:  Yu-jing Bai; Lv-zhen Huang; Ai-yi Zhou; Min Zhao; Wen-zhen Yu; Xiao-xin Li
Journal:  J Ocul Pharmacol Ther       Date:  2013-04-01       Impact factor: 2.671

4.  Pigment epithelium-derived factor suppresses ischemia-induced retinal neovascularization and VEGF-induced migration and growth.

Authors:  Elia J Duh; Hoseong S Yang; Izumi Suzuma; Masaru Miyagi; Elaine Youngman; Keisuke Mori; Miyuki Katai; Lin Yan; Kiyoshi Suzuma; Karen West; Shekar Davarya; Patrick Tong; Peter Gehlbach; Joel Pearlman; John W Crabb; Lloyd P Aiello; Peter A Campochiaro; Donald J Zack
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-03       Impact factor: 4.799

5.  Expression of pigment epithelium-derived factor in normal adult rat eye and experimental choroidal neovascularization.

Authors:  Nahoko Ogata; Mitsumasa Wada; Tsuyoshi Otsuji; Nobuo Jo; Joyce Tombran-Tink; Miyo Matsumura
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-04       Impact factor: 4.799

6.  Pigment epithelium-derived factor is deficient in the vitreous of patients with choroidal neovascularization due to age-related macular degeneration.

Authors:  Nancy M Holekamp; Noel Bouck; Olga Volpert
Journal:  Am J Ophthalmol       Date:  2002-08       Impact factor: 5.258

7.  Oxygen-induced retinopathy in the mouse.

Authors:  L E Smith; E Wesolowski; A McLellan; S K Kostyk; R D'Amato; R Sullivan; P A D'Amore
Journal:  Invest Ophthalmol Vis Sci       Date:  1994-01       Impact factor: 4.799

8.  Quantification of oxygen-induced retinopathy in the mouse: a model of vessel loss, vessel regrowth and pathological angiogenesis.

Authors:  Kip M Connor; Nathan M Krah; Roberta J Dennison; Christopher M Aderman; Jing Chen; Karen I Guerin; Przemyslaw Sapieha; Andreas Stahl; Keirnan L Willett; Lois E H Smith
Journal:  Nat Protoc       Date:  2009-10-08       Impact factor: 13.491

9.  Vitreous levels of proteins implicated in angiogenesis are modulated in patients with retinal or choroidal neovascularization.

Authors:  Matthias Huber; Joachim Wachtlin
Journal:  Ophthalmologica       Date:  2012-08-04       Impact factor: 3.250

10.  Long-term retinal PEDF overexpression prevents neovascularization in a murine adult model of retinopathy.

Authors:  Virginia Haurigot; Pilar Villacampa; Albert Ribera; Assumpcio Bosch; David Ramos; Jesus Ruberte; Fatima Bosch
Journal:  PLoS One       Date:  2012-07-20       Impact factor: 3.240

View more
  1 in total

1.  Inhibition of retinal neovascularization by a PEDF-derived nonapeptide in newborn mice subjected to oxygen-induced ischemic retinopathy.

Authors:  Nader Sheibani; Ismail S Zaitoun; Shoujian Wang; Soesiawati R Darjatmoko; Andrew Suscha; Yong-Seok Song; Christine M Sorenson; Victor Shifrin; Daniel M Albert; Ignacio Melgar-Asensio; Irawati Kandela; Jack Henkin
Journal:  Exp Eye Res       Date:  2020-04-06       Impact factor: 3.467

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.